
BD and ChemoGLO™ partner to expand hazardous drug contamination testing for facilities and labs. Dec. 4, 2025. (NYSE: BDX)
On December 4, 2025, in Franklin Lakes, New Jersey, BD (Becton, Dickinson and Company), a prominent worldwide medical technology enterprise listed on the NYSE with the ticker symbol BDX, teamed up with ChemoGLO™, a renowned expert in detecting and decontaminating hazardous drugs. This collaboration has been established with the aim of progressing initiatives related to hazardous drug safety.

